BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1604492)

  • 1. Prolongation of rat heart allograft survival using cyclosporine and enisoprost, a prostaglandin E1 analog.
    Fabrega AJ; Blanchard J; Rivas PA; Moran SM; Pollak R
    Transplantation; 1992 Jun; 53(6):1363-4. PubMed ID: 1604492
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of the prostaglandin analogues misoprostil and enisoprost on the synergy between donor-specific transfusion and cyclosporine in allograft survival.
    Cofer BR; Davies CB; Alexander JW; Tchervenkov JI
    Transplantation; 1992 Nov; 54(5):941-3. PubMed ID: 1440866
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive effect of misoprostol: a new synthetic prostaglandin E1 analogue.
    Wiederkehr JC; Dumble L; Pollak R; Moran M
    Aust N Z J Surg; 1990 Feb; 60(2):121-4. PubMed ID: 2109591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of leflunomide in a cardiac allograft model.
    Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors determining prolongation of rat heart allograft survival by perioperative injection of donor spleen cells.
    Westra AL; Petersen AH; Wildevuur CR; Prop J
    Transplantation; 1991 Oct; 52(4):606-10. PubMed ID: 1926338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a PGE-1 analogue on the survival of cardiac transplant rats.
    Gracida Juárez C; Mechor Ortíz JL; Mozes MF
    Arch Med Res; 1992; 23(1):55-8. PubMed ID: 1308792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combined therapy with prostaglandin E1 and cyclosporine A on rat heart allograft survival.
    Ozawa T; Kamada N; Ashizawa T; Aoki T; Koyanagi Y; Kimura K
    Transplant Proc; 1991 Aug; 23(4):2213-4. PubMed ID: 1871850
    [No Abstract]   [Full Text] [Related]  

  • 11. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
    Boyle MJ; Dumble LJ
    Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine-sparing influence of the synthetic PGE1 analogue enisoprost in rabbit cardiac allograft recipients.
    Mitchell SV; Dumble LJ; Plenter RJ; Millar RJ; Moran M; Clunie GJ
    Transplant Proc; 1992 Feb; 24(1):229-30. PubMed ID: 1539259
    [No Abstract]   [Full Text] [Related]  

  • 13. Superiority of continuous infusion of prednisolone over daily injections in the prolongation of heart allograft survival in rats.
    Provoost AP; de Keijzer MH; Kort WJ; Wolff ED
    Transplantation; 1982 Oct; 34(4):221-2. PubMed ID: 6755832
    [No Abstract]   [Full Text] [Related]  

  • 14. Tautomycetin as a novel immunosuppressant in transplantation.
    Han DJ; Jeong YL; Wee YM; Lee AY; Lee HK; Ha JC; Lee SK; Kim SC
    Transplant Proc; 2003 Feb; 35(1):547. PubMed ID: 12591525
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model.
    Richter MH; Richter H; Barten M; Schramm D; Weinert M; Gummert J; Mohr FW; Olbrich HG
    Transplant Proc; 2002 Aug; 34(5):1479-80. PubMed ID: 12176448
    [No Abstract]   [Full Text] [Related]  

  • 16. Moderate additive immunosuppressive effect of thalidomide combined with cyclosporin A in rat cardiac transplantation.
    Ostraat O; Qi Z; Gannedahl G; Tufveson G; Ekberg H
    Transpl Immunol; 1996 Sep; 4(3):241-6. PubMed ID: 8893456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of rat ear allograft survival with cyclosporine.
    Chiu DT; Ascherman JA; Patsis MC
    Transplantation; 1993 Jul; 56(1):253-5. PubMed ID: 8333062
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection.
    Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC
    Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prostaglandin E1 on the prolongation of rat cardiac allograft survival.
    Imura M; Higashi K; Yada I; Namikawa S; Yuasa H; Kusagawa M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1312-5. PubMed ID: 3547863
    [No Abstract]   [Full Text] [Related]  

  • 20. Different effects of sandimmun and neoral on migration of lymph cells to allograft and lymphoid tissue.
    Maksymowicz M; Olszewski WL; Zaleska M
    Transplant Proc; 2000 Sep; 32(6):1400-2. PubMed ID: 10995995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.